India’s Sun Pharma Gets Tentative Nod for New Drug From FDA

India’s Sun Pharmaceutical Industries announced over the weekend that its US-based subsidiary has got tentative approval from the Food and Drug Administration (FDA) to market a generic drug for the treatment of Alzheimer’s disease.
TradingMarkets